Evidence map›Paper›PMID 20197544›Full record

ArticleScience signaling2010

Polycomb group proteins as epigenetic mediators of neuroprotection in ischemic tolerance.

Martha Stapels, Chelsea Piper, Tao Yang, Minghua Li, Cheri Stowell, Zhi-gang Xiong, Julie Saugstad, Roger P Simon, Scott Geromanos, James Langridge and 2 more

Abstract read
In one paragraph

Article in Science signaling, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Role of NADCellular and molecular neurobiology · 2023
    Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Distinct plasma proteomic changes in male and female African American stroke patients.International journal of physiology, pathophysiology and pharmacology · 2019
    Article
  15. Review
  16. Article
  17. Early Rehabilitation After Stroke: a Narrative Review.Current atherosclerosis reports · 2017
    Review
  18. Review
  19. Article
  20. Review

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Martha StapelsWaters Corporation, Milford, MA 01757, USA.
Chelsea Piper
Tao Yang
Minghua Li
Cheri Stowell
Zhi-gang Xiong
Julie Saugstad
Roger P Simon
Scott Geromanos
James Langridge
Jing-quan Lan
An Zhou

Funding

New Gene Expression in Cell Culture Models of IschemiaP01NS035965 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SIMON, ROGER PANCOAST · 1997 to 2007
$9.4M
Acid-sensing channels as novel target for brain ischemiaR01NS047506 · NINDS · MOREHOUSE SCHOOL OF MEDICINE · PI XIONG, ZHIGANG · 2004 to 2010
$1.7M
A Novel Intervention Strategy for Stroke with RTL TherapyR42NS065515 · NINDS · VIROGENOMICS, INC. · PI ALKAYED, NABIL J, OFFNER, HALINA · 2012 to 2013
$1.4M
Brain ischemia attenuates neuropeptide biosynthesisR01NS046560 · NINDS · LEGACY EMANUEL HOSPITAL AND HEALTH CENTER · PI ZHOU, AN · 2005 to 2008
$1.2M
Acid-sensing channels as novel target for brain ischemiaR56NS047506 · NINDS · LEGACY EMANUEL HOSPITAL AND HEALTH CENTER · PI XIONG, ZHIGANG · 2009 to 2009
$394k
NINDS NIH HHS 1R01NS046560NINDS NIH HHS 5P01NS035965NINDS NIH HHS P01 NS035965NINDS NIH HHS R01 NS046560NINDS NIH HHS R01 NS047506NINDS NIH HHS R01NS47506NINDS NIH HHS R42 NS065515NINDS NIH HHS R56 NS047506
6 · The paper itself

Abstract

Exposing the brain to sublethal ischemia affects the response to a subsequent, otherwise injurious ischemia, resulting in transcriptional suppression and neuroprotection, a response called ischemic tolerance. Here, we show that the proteomic signature of the ischemic-tolerant brain is characterized by increased abundance of transcriptional repressors, particularly polycomb group (PcG) proteins. Knocking down PcG proteins precluded the induction of ischemic tolerance, whereas in an in vitro model, overexpressing the PcG proteins SCMH1 or BMI1 induced tolerance to ischemia without preconditioning. We found that PcG proteins are associated with the promoter regions of genes encoding two potassium channel proteins that show decreased abundance in ischemic-tolerant brains. Furthermore, PcG proteins decreased potassium currents in cultured neuronal cells, and knocking down potassium channels elicited tolerance without preconditioning. These findings reveal a previously unknown mechanism of neuroprotection that involves gene repressors of the PcG family.

Indexed as

AnimalsBase SequenceBrain IschemiaEpigenesis, GeneticIn Vitro TechniquesKv1.5 Potassium ChannelMaleMiceMice, Inbred C57BLNeuroprotective AgentsNuclear ProteinsPolycomb-Group ProteinsPolycomb Repressive Complex 1Promoter Regions, GeneticProteomicsProto-Oncogene ProteinsBmi1 protein, mouseKcna5 protein, mouseKcnab2 protein, mouseKv1.5 Potassium ChannelNeuroprotective AgentsNuclear ProteinsPolycomb-Group ProteinsPolycomb Repressive Complex 1Proto-Oncogene ProteinsRepressor ProteinsRNA, Small InterferingScmh1 protein, mouseShaker Superfamily of Potassium Channels

Identifiers

PMID20197544
PMCPMC3878609

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.